Wyden Announces Finance Committee Hearing Examining Prescription Drug Shortages
WASHINGTON, D.C. – Senate Finance Committee Chairman Ron Wyden, D-Ore., will convene a committee hearing on Tuesday, December 5, 2023 titled “Drug Shortages: Examining Supply Challenges, Impacts, and Policy Solutions from a Federal Health Program Perspective.” The hearing will take place at 10:00 a.m. in Room 215 of the Dirksen Senate Office Building.
The witnesses at Wednesday’s hearing will be:
- Inmaculada Hernandez, PharmD., Ph.D., Professor, Division of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA
- Marta E. Wosi?ska, Ph.D., Senior Fellow, Schaeffer Initiative on Health Policy, The Brookings Institution, Washington, DC
- Allan Coukell, Senior Vice President of Public Policy, Civica Rx, Lehi, UT
- Jason Westin, MD, MS, FACP, Director, Lymphoma Clinical Research Program, Section Chief, Aggressive Lymphoma, Department of Lymphoma & Myeloma, M.D. Anderson Cancer Center, Houston, TX
Who: Senate Finance Committee
What: Committee hearing examining prescription drug shortages
Where: 215 Dirksen Senate Office Building
Washington, D.C. 20510
When: Tuesday, December 5, 2023
10:00 a.m.
Media are encouraged to attend the hearing or to view the webcast and witness testimony at http://finance.senate.gov/hearings.
###
Next Article Previous Article